CHST11 and hepatocellular carcinoma: Multivariate COX analysis further revealed that CHST11 mRNA and TNM stage were independent prognostic biomarkers in HCC (CHST11: HR = 1.122, 95% CI = 1.008–1.249, p = 0.035; TNM stage: HR = 1.517, 95% CI = 1.089–2.114, p = 0.014; Figure 2E).